
Chemical and Pharmaceutical Bulletin p. 3206 - 3213 (1992)
Update date:2022-07-29
Topics:
Tanaka
Ito
Nishino
Motoyama
Takasugi
5-Alkyl-2-aryl-4-pyridylimidazoles were synthesized and tested in rat ex vivo platelet aggregation studies. Among these compounds, 2-(2-fluorophenyl)-5-methyl-4-(3-pyridyl)imidazole (25) was most potent, and showed 98% inhibition at a dose of 10 mg/kg (p.o.). 25 had inhibitory activity on cyclooxygenase, thromboxane A2 (TXA2) synthetase, and phosphodiesterase, and also showed inhibited KCl-induced contraction of rat aorta. All compounds have little acute toxicity and appear to be free of adverse effects on the stomach.
View MoreContact:0086 533 2282832
Address:Zibo,Shandong
zhuzhou zhongle chemical co. ltd.
Contact:+86-0731 28228409
Address:Zhuzhou, Hunan, China
taizhou creating bio-pharm co.,ltd.
Contact:+86- 576- 88827176
Address:715 room ,unit A.junyue Building,Jiaojiang,Taizhou,Zhejiang,China
Contact:0571-
Address:zhejing
Contact:86-021-52418058
Address:8/F, Building 6, Guiping Road No.333, Shanghai, 200233, China
Doi:10.1021/ol006737a
(2001)Doi:10.1016/j.tet.2009.06.006
(2009)Doi:10.1007/s00706-013-1120-6
(2014)Doi:10.1002/anie.201913132
(2020)Doi:10.1021/ja01516a039
(1959)Doi:10.1021/cg2002628
(2011)